Faculty profile

Yingwei Peng

ResearcherPublic Health Sciences/Mathematics and StatisticsQueen's University

This profile is built from public research funding records (CIHR, NSERC and SSHRC) and PubMed. We have not imported them from a Queen's University directory, so their courses may be missing. Find their university profile.

Yingwei Peng

Researcher

Public Health Sciences/Mathematics and Statistics

Natural Sciences

Queen's University

Kingston, Ontario, Canada

Supervision signals

Has led research grants, which requires an independent research appointment. Ask their department whether they supervise graduate students.
18 publications in the last five years, latest in 2026.
Senior (last) author on 8 recent papers, a sign of leading a research group.
Principal investigator on 5 research grants (5 NSERC), most recently in 2024.

These signals come from public records, including CIHR, NSERC and SSHRC funding decisions. Ask the professor or the graduate program whether they are taking new students.

Academic metrics

Publications

Citations

Collaborators

Grants

Publications by year

Counts cover the publications linked to this profile. Citations and the h-index appear when the source records them.

Profiles and links

Search on Google Scholar

Find them onX · LinkedIn · Bluesky · YouTube

Signals and details

Research

survival models censored data longitudinal data cure models machine learning methods causal inference statistical methods for big data joint modeling

Latest papers

HIV-sex interaction effect on risk of hepatitis C-related cirrhosis, decompensation, and hepatocellular carcinoma.
AIDS (London, England) · 2026 · senior author
Four methods for estimating hepatitis C incidence using extant testing data.
PloS one · 2026 · senior author
Liver disease risk attributable to HCV, HIV, and HCV-HIV coinfection: an interaction analysis.
AIDS (London, England) · 2026

All 70 publications

Latest funding

Novel statistical models and learning methods for complex event history data
NSERC · 2024 · Principal investigator
$38,000
Infective Endocarditis Treatment & Outcomes in Persons Who Inject Drugs
CIHR · 2024 · Co-investigator
$481,952
Real-World Outcomes Associated with PARP Inhibitor Maintenance Therapy in Ovarian Cancer: A Population-Based Study
CIHR · 2022 · Co-investigator
$100,000

All 16 grants and awards

70 publications.

HIV-sex interaction effect on risk of hepatitis C-related cirrhosis, decompensation, and hepatocellular carcinoma.

McFarlane WJ, Brogly SB, Flemming JA, Martinez-Cajas J, Peng Y

AIDS (London, England)2026Senior author

DOI: 10.1097/qad.0000000000004501 PMID: 41879085

Four methods for estimating hepatitis C incidence using extant testing data.

McFarlane WJ, Flemming JA, Brogly SB, Peng Y

PloS one2026Senior author

DOI: 10.1371/journal.pone.0335115 PMID: 42268826

Liver disease risk attributable to HCV, HIV, and HCV-HIV coinfection: an interaction analysis.

McFarlane WJ, Flemming JA, Martinez-Cajas JL, Peng Y, Brogly SB

AIDS (London, England)2026

DOI: 10.1097/qad.0000000000004555 PMID: 42186787

A quantile cure model with partially functional covariate effects.

Chen CM, Peng Y

Statistical methods in medical research2026Senior author

DOI: 10.1177/09622802261445414 PMID: 42175820

Nonparametric estimation of average effects of a continuous treatment for survival data with a cured fraction.

Liu H, Peng Y

Lifetime data analysis2026Senior author

DOI: 10.1007/s10985-026-09703-3 PMID: 41912742

A gradient boosting decision tree based estimation method for the mixture cure model.

Zheng J, Li P, Peng Y

Journal of applied statistics2026Senior author

DOI: 10.1080/02664763.2025.2520337 PMID: 41783277

Recommendations for studying the association of the cancer diagnosis to treatment interval with overall survival: a modified Delphi process.

Jalink M, King WD, Anderson BO, Sutradhar R, Tørring ML, Brundage MD, Groome PA, Chan KKW, Urquhart R, Peng Y, Eskander A, Grover S, Raphael MJ, Grieve R, Laub C, Booth CM, Hanna TP

British journal of cancer2025

DOI: 10.1038/s41416-025-03158-3 PMID: 40908299

Marginal semiparametric accelerated failure time cure model for clustered survival data.

Niu Y, Fan D, Ding J, Peng Y

Statistical methods in medical research2025Senior author

DOI: 10.1177/09622802241295335 PMID: 39659151

A New Approach to Modeling the Cure Rate in the Presence of Interval Censored Data.

Pal S, Peng Y, Aselisewine W

Computational statistics2024

DOI: 10.1007/s00180-023-01389-7 PMID: 39176239

A Frailty Index to Predict Mortality, Resource Utilization and Costs in Patients Undergoing Coronary Artery Bypass Graft Surgery in Ontario.

Johnson A, Hore E, Milne B, Muscedere J, Peng Y, McIsaac DI, Parlow J

CJC open2024

DOI: 10.1016/j.cjco.2023.10.010 PMID: 38585676

Novel statistical models and learning methods for complex event history data

Principal investigatorNSERC2024Discovery Grants Program - Individual

Principal investigators: Peng, Yingwei

Keywords: survival models; censored data; longitudinal data; cure models; machine learning methods; causal inference; statistical methods for big data; joint modeling

$38,000

Infective Endocarditis Treatment & Outcomes in Persons Who Inject Drugs

Co-investigatorCIHR2024Project Grant

Principal investigators: Brogly, Susan B

Keywords: Causal Methods; Infective Endocarditis; Observational Cohort; Substance Use Disorder

$481,952

Real-World Outcomes Associated with PARP Inhibitor Maintenance Therapy in Ovarian Cancer: A Population-Based Study

Co-investigatorCIHR2022Project Grant - PA: Health Economics/Health Services Research in Cancer Control

Principal investigators: Ethier, Josee-Lyne

Keywords: Cost-Effectiveness; Niraparib; Olaparib; Outcomes; Ovarian Cancer; Overall Survival; Parp Inhibitors; Progression-Free Survival; Real-World Evidence; Toxicity

$100,000

Statistical models and methods for survival and longitudinal data in clinical and observational studies

Principal investigatorNSERC2018Discovery Grants Program - Individual

Principal investigators: Peng, Yingwei

$168,000

Real world outcomes of novel targeted agents for the treatment of metastatic HER-2 positive breast cancer in Ontario: A population-based study

Co-investigatorCIHR2018Operating Grant: Data Analysis Using Existing Databases and Cohorts

Principal investigators: Ethier, Josee-Lyne

Keywords: Breast Cancer; Health Services Research; Her-2 Positive Breast Cancer; Metastatic Breast Cancer; Pertuzumab; Real-World Outcomes; Trastuzumab Emtansine

$97,999

Can Early Palliative Care for Non-Small Cell Lung Cancer Improve End-of-Life Outcomes and Reduce Cost in the Real World? A Population-Based Study

Co-investigatorCIHR2017Operating Grant: Secondary Data Analysis for Cancer Prevention and Control

Principal investigators: Goldie, Catherine L; Hanna, Timothy P

Keywords: Administrative Data; Economic; End Of Life; Lung Cancer; Palliative Care; Quality Indicators

$74,853

Imaging use for low back pain by primary care practitioners

Co-investigatorCIHR2016Project Grant

Principal investigators: French, Simon D; Bhatia, Rajan S; Green, Michael E; Norman, Kathleen E

Keywords: Administrative Data Analysis; Cohort Study; Implementation Science; Low Back Pain; Primary Care; Qualitative Study; Quality Improvement And Safety

$707,626

Optimizing the Use of Adjuvant Chemotherapy for Colon Cancer: A Population-Based Study of Practice and Outcomes

Co-investigatorCIHR2015Operating Grant

Principal investigators: Booth, Christopher M

Keywords: Chemotherapy; Colon Cancer; Health Services Research; Outcomes; Patterns Of Care; Quality Of Care; Surgery

$218,101

A Population Study of the Toxicity and Effectiveness of High-Dose Interferon for High-Risk Melanoma

Co-investigatorCIHR2014Operating Grant

Principal investigators: Hanna, Timothy P

Keywords: Drug Therapy; Effectiveness; Health Services Research; Interferon (High-Dose); Melanoma; Population-Level Study; Quality; Safety; Survival; Toxicity

$360,993

Novel statistical models and estimation methods for survival and longitudinal data.

Principal investigatorNSERC2013Discovery Grants Program - Individual

Principal investigators: Peng, Yingwei

$75,000

From CIHR, NSERC and SSHRC funding decisions: CIHR since 2008, NSERC since 1991 and SSHRC since 1998, including their latest published competition results.

Something wrong or missing on this profile? Suggest a correction

Yingwei Peng

Research

Latest papers

Latest funding

HIV-sex interaction effect on risk of hepatitis C-related cirrhosis, decompensation, and hepatocellular carcinoma.

Four methods for estimating hepatitis C incidence using extant testing data.

Liver disease risk attributable to HCV, HIV, and HCV-HIV coinfection: an interaction analysis.

A quantile cure model with partially functional covariate effects.

Nonparametric estimation of average effects of a continuous treatment for survival data with a cured fraction.

A gradient boosting decision tree based estimation method for the mixture cure model.

Recommendations for studying the association of the cancer diagnosis to treatment interval with overall survival: a modified Delphi process.

Marginal semiparametric accelerated failure time cure model for clustered survival data.

A New Approach to Modeling the Cure Rate in the Presence of Interval Censored Data.

A Frailty Index to Predict Mortality, Resource Utilization and Costs in Patients Undergoing Coronary Artery Bypass Graft Surgery in Ontario.

Novel statistical models and learning methods for complex event history data

Infective Endocarditis Treatment & Outcomes in Persons Who Inject Drugs

Real-World Outcomes Associated with PARP Inhibitor Maintenance Therapy in Ovarian Cancer: A Population-Based Study

Statistical models and methods for survival and longitudinal data in clinical and observational studies

Real world outcomes of novel targeted agents for the treatment of metastatic HER-2 positive breast cancer in Ontario: A population-based study

Can Early Palliative Care for Non-Small Cell Lung Cancer Improve End-of-Life Outcomes and Reduce Cost in the Real World? A Population-Based Study

Imaging use for low back pain by primary care practitioners

Optimizing the Use of Adjuvant Chemotherapy for Colon Cancer: A Population-Based Study of Practice and Outcomes

A Population Study of the Toxicity and Effectiveness of High-Dose Interferon for High-Risk Melanoma

Novel statistical models and estimation methods for survival and longitudinal data.

Frequent collaborators

Dongsheng Tu

David Berman

Colleen Webber

Michael Brundage

Sumit Gupta

Wenyu Jiang

Tara Gomes

Monika Krzyzanowska

Ralph Meyer

Claudio Soares

John Muscedere

Rinku Sutradhar

Nicola Schieda

Julie Theurer

Antoine Eskander

Ana Johnson

William Pickett

Robin Urquhart

Erin Kennedy